Search Results
68 items found for "Omass Therapeutics"
- AGPCR 24 Session I
Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA; Division of Molecular Therapeutics, New York State contribute to a deeper understanding of the signaling mechanisms of aGPCRs, which could inform future therapeutic
- Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
Therefore, our findings demonstrated that GPR37 may represent a viable therapeutic target for NSCLC."
- The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor
controlling the functions of monocytes and dendritic cells and that targeting GPR141 may be a possible therapeutic
- Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia
Ultra-performance liquid chromatography-mass spectrometry was used for compound separation and characterization A dynamic mass redistribution technique was applied to evaluate compounds on four GPCRs.
- RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway
inhibition of the PKA-Hippo signaling pathway Published date March 2, 2024 Abstract " Background: Novel therapeutic
- AGPCR 24 Session II
understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
These findings provide a promising therapeutic approach to selectively induce ferroptosis in glioblastoma
- AGPCR 24 Session VII
Javitch1,2 1Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University , New York, NY 10032; 2Division of Molecular Therapeutics, New York State Psychiatric Institute, New
- Ep 145 with Dr John Janetzko
Over the course of my graduate work, I gained experience with structural mass spectrometry and protein My postdoc work has made use of several techniques including various mass spectrometry approaches, single
- AGPCR 24 Session VIII
GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic
- AGPCR 24 Student Flash Presentations
graduate student, he worked in the EuGEF Research Group to identify novel prognostic biomarkers and therapeutic
- Content and Conduct Policy | Dr. GPCR Ecosystem
Spam Do not spam, including by sending unwanted promotional or commercial content, or unwanted or mass